Cardiovascular safety profiles of proteasome inhibitors: an eudravigilance based disproportionality analysis

11 May 2026 (08:30 - 09:47)
Organised by: Logo
Congress Presentation Part of: ePosters in cardiovascular disease in special populations (2) Cardio-Oncology Delegates Premium Access Heart Failure 2026 Heart Failure Association (HFA)

ESC 365 is supported by

ESC 365 is supported by